Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20213
20224
20236
20244
202510

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
Sanofi2
UCB Biopharma SRL2
Vertex Pharmaceuticals Incorporated2
AbbVie1
Alnylam Pharmaceuticals1
AstraZeneca1
Astria Therapeutics, Inc.1
Avidity Biosciences, Inc.1
BioCryst Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angioedemas, Hereditary3
Amyloidosis2
Connective Tissue Diseases2
Epilepsy2
Myotonic Dystrophy2
Seizures2
Anemia, Sickle Cell1
Angioedema1
Asthma1
Cardiomyopathies1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.